pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

4,900 catalysts · 4,686 phase readout · 2,347 8k filing · 285 earnings · 201 pdufa · 172 phase 2 completion · 73 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-20: 0 catalysts2026-07-21: 0 catalysts2026-07-22: 14 catalysts2026-07-23: 2 catalysts2026-07-24: 1 catalyst2026-07-25: 0 catalysts2026-07-26: 0 catalysts2026-07-27: 2 catalysts2026-07-28: 4 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 0 catalysts2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: approval×type: patent expiry×type: pdufa×type: phase readout×clear all
type
  • phase readout4,686
  • 8k filing2,347
  • earnings285
  • pdufa201
  • phase 2 completion172
  • phase 1 completion73
phase 2 initiation
62
  • phase 1 initiation40
  • phase 1 2 completion35
  • phase 0 trial completion23
  • therapy area
    • Infectious Disease10
    • Dermatology2
    • Oncology2
    • Pulmonology1

    Week of Apr 20, 2026

    4
    ›Apr 24, 2026patent expiry90d agoDaiichi Sankyo Co Ltd — laninamivir (Constraining Patent Expiry (Japan))laninamivir

    Therapy area: Infectious Disease, Respiratory. Indication: Asthma, Influenzavirus A Infections, Influenzavirus B Infections

    full page →laninamivir →source: globaldata
    ›Apr 24, 2026patent expiry90d agoEisai Co Ltd — lenvatinib mesylate (Constraining Patent Expiry (US))lenvatinib mesylate

    Therapy area: Gastrointestinal, Infectious Disease, Oncology. Indication: Acral Lentiginous Melanoma, Adenocarcinoma Of The Gastroesophageal Junction, Adenoid Cystic Carcinoma (ACC), Adrenocortical Carcinoma (Adrenal Cortex Cancer), Anaplastic Thyroid Cancer, Bile Duct Cancer (Cholangiocarcinoma), Bladder Cancer, Breast Cancer, Colorectal Cancer, Cutaneous Squamous Cell Carcinoma (cSCC), Endometrial Cancer, Ependymoma, Epithelial Ovarian Cancer, Esophageal Squamous Cell Carcinoma (ESCC), Ewing S

    full page →lenvatinib mesylate →source: globaldata
    ›Apr 25, 2026patent expiry89d agoStemline Therapeutics Inc — SL-901 (Constraining Patent Expiry (Japan))SL-901

    Therapy area: Oncology, Undisclosed. Indication: Lung Cancer, Solid Tumor, Unspecified Rare Disease

    full page →SL-901 →source: globaldata
    ›Apr 26, 2026patent expiry88d agoBlue Blood Biotech Corp — BB-101 (Constraining Patent Expiry (Japan))BB-101

    Therapy area: Dermatology. Indication: Diabetic Foot Ulcers

    full page →BB-101 →source: globaldata

    Week of Apr 27, 2026

    11
    ›Apr 27, 2026patent expiry87d agoBill & Melinda Gates Medical Research Institute — SB-692342 (Constraining Patent Expiry (Japan))SB-692342

    Therapy area: Infectious Disease. Indication: Pulmonary Tuberculosis

    full page →SB-692342 →source: globaldata
    ›Apr 27, 2026pdufa

    Week of Jun 1, 2026

    35
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d ago
    ← prev
    page 1 of 98
    next →
    87d ago
    Regeneron Pharmaceuticals Inc — dupilumab (PDUFA)dupilumab

    Therapy area: Dermatology. Indication: Chronic Urticaria

    full page →dupilumab →source: globaldata
    ›Apr 28, 2026patent expiry86d agoGSK plc — dolutegravir sodium ODT (Constraining Patent Expiry (Japan))dolutegravir sodium

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →dolutegravir sodium →source: globaldata
    ›Apr 28, 2026patent expiry86d agoGSK plc — (abacavir sulfate + dolutegravir sodium+ lamivudine) ODT (Constraining Patent Expiry (Japan))(abacavir sulfate + dolutegravir sodium + lamivudine)

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →(abacavir sulfate + dolutegravir sodium + lamivudine) →source: globaldata
    ›Apr 28, 2026patent expiry86d agoGSK plc — cabotegravir sodium (Constraining Patent Expiry (US))cabotegravir sodium

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →cabotegravir sodium →source: globaldata
    ›Apr 28, 2026patent expiry86d agoViiV Healthcare UK Ltd — cabotegravir + rilpivirine LA (Constraining Patent Expiry (US))cabotegravir + rilpivirine LA

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →cabotegravir + rilpivirine LA →source: globaldata
    ›Apr 28, 2026patent expiry86d agoViiV Healthcare UK Ltd — cabotegravir LA (Constraining Patent Expiry (US))cabotegravir LA

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →cabotegravir LA →source: globaldata
    ›Apr 28, 2026pdufa86d agoMerck & Co Inc — (doravirine + islatravir hydrate) (PDUFA)(doravirine + islatravir hydrate)

    Therapy area: Infectious Disease. Indication: Human Immunodeficiency Virus (HIV) Infections (AIDS)

    full page →(doravirine + islatravir hydrate) →source: globaldata
    ›Apr 29, 2026pdufa85d agoSanofi — teplizumab (PDUFA)teplizumab

    Therapy area: Metabolic Disorders. Indication: Type 1 Diabetes (Juvenile Diabetes)

    full page →teplizumab →source: globaldata
    ›Apr 30, 2026patent expiry84d agoBasilea Pharmaceutica Ltd — isavuconazonium sulfate (Constraining Patent Expiry (US))isavuconazonium sulfate

    Therapy area: Infectious Disease. Indication: Aspergillosis, Candidiasis, Cryptococcal Meningitis, Cryptococcosis, Zygomycosis (Mucormycosis)

    full page →isavuconazonium sulfate →source: globaldata
    ›Apr 30, 2026pdufa84d agoAxsome Therapeutics Inc — (bupropion hydrochloride + dextromethorphan) ER (PDUFA)(bupropion hydrochloride + dextromethorphan) ER

    Therapy area: Central Nervous System. Indication: Dementia Associated With Alzheimer's Disease

    full page →(bupropion hydrochloride + dextromethorphan) ER →source: globaldata
    Test PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    ›Jun 1, 2026pdufa52d agoTest PDUFA

    No description on file. Bork keeps sniffing.

    full page →source: test
    $REGN672.45-0.41%
    $GSK50.78+1.48%
    $GSK50.78+1.48%
    $GSK50.78+1.48%
    $AXSM236.95+6.91%
    $MRK126.26+1.50%
    $SNY44.12+0.85%